Danaher Corp
This week’s most effective-doing stocks include things like a pharma identify up more than 20%
Wall Avenue is wrapping up a volatile week, but some stocks nonetheless did well inspite of several macro crosscurrents. The S & P 500 is down 1.4% week to date, on speed for its largest weekly decrease considering that December. The Dow Jones Industrial Typical and Nasdaq Composite were also reduce for the week. Individuals […]
Read More
Cramer’s lightning round: Parker-Hannifin is a buy
Parker-Hannifin Corp: “It’s just the kind of industrial I’ve been recommending. … I would buy it here.” Conocophillips: “That thing is like a fine Merlot, my friend. I would buy all you can right here.” Snowflake Inc: “I like Snowflake. I will go with [CEO Frank] Slootman. He is a money maker.” Zscaler Inc: “The […]
Read More
Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter
Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity. Revenue increased nearly 10% on a core basis to $8.37 billion, well above estimates of $7.9 billion, according to Refinitiv. Adjusted profit increased 6.7% to $2.87 […]
Read More
Jim Cramer’s Investing Club meeting Tuesday: J&J, Danaher, AMD
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Buy JNJ while it’s down Look to buy Danaher Wait to buy AMD 1. Buy JNJ while it’s down Shares of Johnson & Johnson (JNJ) slipped more than 1% Tuesday […]
Read More
2 of our stocks get nice pops. Here’s the news and what we think
As Wall Street on Tuesday attempted to hold onto recent gains, we received positive updates on two Club holdings that are seeing outsized moves to the upside: Danaher (DHR) and Constellation Brands (STZ). DHR 1Y mountain Danaher’s 1 year stock performance Danaher is set to present at the JPMorgan Healthcare Conference on Tuesday afternoon. However, […]
Read More
Stocks making the biggest moves midday: Bed Bath & Beyond, Coinbase, Virgin Orbit and more
In this article DISH ON 5CV-DE ILMN BMBL OSH BBBY COIN Follow your favorite stocksCREATE FREE ACCOUNT Virgin Orbit’s LauncherOne rocket on display in Times Square, New York. CNBC | Michael Sheetz Check out the companies making the biggest moves midday: Virgin Orbit — The satellite launch service company fell 12% a day after it […]
Read More
Jim Cramer says these 5 Nasdaq losers could rebound in 2023
CNBC’s Jim Cramer on Friday named four stocks that he believes could mount a comeback this year. To come up with his picks, he parsed through last year’s worst-performing stocks listed in the Nasdaq 100. “Out of the Nasdaq’s biggest losers, I think Qualcomm, Lam Research, Micron, and Airbnb will work this year, although not […]
Read More
Jim Cramer’s Investing Club meeting Thursday: Avoid expensive stocks
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Avoid expensive stocks Sticking by Danaher Still a buyer of Ford 1. Avoid expensive stocks Stocks continued their drop on Thursday after the December ADP private payrolls report indicated the […]
Read More
Credit Suisse downgrades Danaher as Covid vaccine demand dwindles
Credit Suisse is shifting its perspective on shares of Danaher as the company’s bioprocess business comes under pressure. Analyst Dan Leonard downgraded the medical stock to neutral from outperform, citing exposure to bioprocessing inventory reductions that could threaten Danaher’s growth. “Danaher has reduced its near-term growth expectations for its Bioprocess business (~25% of 2022e sales, […]
Read More
Jim Cramer recommends these 5 healthcare stocks in 2023
CNBC’s Jim Cramer on Thursday presented investors with a roster of healthcare stocks that should be on their shopping lists for next year. “Wall Street likes profitable companies with consistent results, nice dividends and reasonably-valued stocks,” he said, adding, “The biggest [healthcare] winners were boring, consistent operators with cheap stocks.” Cramer said that healthcare stocks […]
Read More